512.75

+2.85%↑

CTAS

194.03

+0.72%↑

FDX

313.17

+1.15%↑

HEICO

351.37

-0.21%↓

HEICA

270.71

+0.37%↑

512.75

+2.85%↑

CTAS

194.03

+0.72%↑

FDX

313.17

+1.15%↑

HEICO

351.37

-0.21%↓

HEICA

270.71

+0.37%↑

512.75

+2.85%↑

CTAS

194.03

+0.72%↑

FDX

313.17

+1.15%↑

HEICO

351.37

-0.21%↓

HEICA

270.71

+0.37%↑

512.75

+2.85%↑

CTAS

194.03

+0.72%↑

FDX

313.17

+1.15%↑

HEICO

351.37

-0.21%↓

HEICA

270.71

+0.37%↑

512.75

+2.85%↑

CTAS

194.03

+0.72%↑

FDX

313.17

+1.15%↑

HEICO

351.37

-0.21%↓

HEICA

270.71

+0.37%↑

Home・Akcijų sąrašas・India Globalization Capital Inc

India Globalization Capital Inc

Uždarymo kaina

0.29

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.29

Max

0.29

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-222K -1.8M
Pardavimai	-137K 191K
Pelno marža	-953.403
Darbuotojai	70
EBITDA	62K -1.7M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+1483.33% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-8.1M 27M
Ankstesnė atidarymo kaina	0.29
Ankstesnė uždarymo kaina	0.29

India Globalization Capital Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-14 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

2026-01-15 00:00; UTC

Uždarbis

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

2026-01-14 23:47; UTC

Rinkos pokalbiai

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

2026-01-14 23:44; UTC

Rinkos pokalbiai

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

2026-01-14 23:39; UTC

Rinkos pokalbiai

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

2026-01-14 23:32; UTC

Rinkos pokalbiai

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

2026-01-14 22:56; UTC

Įsigijimai, susijungimai, perėmimai

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

2026-01-14 22:53; UTC

Įsigijimai, susijungimai, perėmimai

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

2026-01-14 22:17; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-14 22:17; UTC

Rinkos pokalbiai

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

2026-01-14 22:09; UTC

Uždarbis

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

2026-01-14 22:08; UTC

Uždarbis

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

2026-01-14 22:08; UTC

Uždarbis

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

2026-01-14 21:53; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

2026-01-14 21:53; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

2026-01-14 21:52; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Announces Positive Profit Alert for 2025

2026-01-14 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup Acting as Financial Advisor to WuXi XDC

2026-01-14 21:51; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC: Aims to Keep Listing Status of BioDlink

2026-01-14 21:51; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

2026-01-14 21:50; UTC

Rinkos pokalbiai

Uždarbis

Financial Services Roundup: Market Talk

2026-01-14 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-14 21:49; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC: BioDlink Offer to Cost HK$2.79B

2026-01-14 21:48; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

2026-01-14 21:48; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Makes Cash Offer for BioDlink International

2026-01-14 21:13; UTC

Rinkos pokalbiai

Oil Retreats Late After Trump Comments on Iran -- Market Talk

2026-01-14 20:30; UTC

Rinkos pokalbiai

Uždarbis

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

2026-01-14 20:13; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

2026-01-14 20:08; UTC

Rinkos pokalbiai

Oil Futures Extend Rally on Iran Tensions -- Market Talk

2026-01-14 19:33; UTC

Rinkos pokalbiai

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

2026-01-14 19:06; UTC

Rinkos pokalbiai

Uždarbis

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Akcijų palyginimas

Kainos pokytis

India Globalization Capital Inc Prognozė

Kainos tikslas

By TipRanks

1483.33% į viršų

12 mėnesių prognozė

Vidutinis 4.75 USD 1483.33%

Aukščiausias 4.75 USD

Žemiausias 4.75 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines India Globalization Capital Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių India Globalization Capital Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Apie bendrovę India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.